Phase 2b program assessing GLPG3667 in psoriasis
Latest Information Update: 16 Jul 2021
At a glance
- Drugs GLPG 3667 (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors Galapagos NV
- 16 Jul 2021 New trial record
- 14 Jul 2021 According to Galapagos NV media release, this trial is expected to initiate next year.